The effect of the expression of angiotensin II on extracellular matrix metalloproteinase inducer (EMMPRIN) in macrophages is mediated via the AT1/COX-2/PGE2 pathway

Inflamm Res. 2010 Dec;59(12):1033-40. doi: 10.1007/s00011-010-0223-3. Epub 2010 Jun 20.

Abstract

Aim: To explore the expression of extracellular matrix metalloproteinase inducer (EMMPRIN) in THP-1 macrophages induced by angiotensin II (Ang II) and the mechanism of EMMPRIN expression.

Methods: THP-1 cells were cultured and induced into macrophages, then stimulated with 10(-6) mol/L Ang II. Levels of EMMPRIN gene and its protein were measured by real-time polymerase chain reaction and western blotting. Prostaglandin E(2) (PGE(2)) expression was assayed by enzyme-linked immunosorbent assay. Antagonists of the angiotensin type-1 receptor (AT(1)R) and angiotensin type-2 receptor (AT(2)R) were used to inhibit the effect of Ang II, and PGE(2) added to detail the mechanism of Ang II-induced EMMPRIN expression.

Results: Ang II clearly induced the expression of EMMPRIN mRNA and protein in macrophages; this expression peaked at 12 h and declined after 24 h. The tendency of enhancement of the levels of cyclooxygenase-2 (COX-2) and PGE(2) was coincident with EMMPRIN expression. AT(1)-receptor antagonists and COX-2 inhibitors inhibited the effect of Ang II, but AT(2)-receptor antagonists did not.

Conclusion: Ang II can up-regulate EMMPRIN expression in THP-1 macrophages via the AT(1)/COX-2/PGE(2) signal transduction pathway, and the effect can be inhibited by losartan and NS-398.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / metabolism*
  • Angiotensin II Type 1 Receptor Blockers / pharmacology
  • Angiotensin II Type 2 Receptor Blockers / pharmacology
  • Animals
  • Basigin
  • Cell Line
  • Cyclooxygenase 2 / metabolism*
  • Cyclooxygenase Inhibitors / pharmacology
  • Dinoprostone / metabolism*
  • Humans
  • Imidazoles / pharmacology
  • Losartan / pharmacology
  • Macrophages / cytology
  • Macrophages / metabolism*
  • Nitrobenzenes / pharmacology
  • Pyridines / pharmacology
  • Receptor, Angiotensin, Type 1 / metabolism*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*
  • Sulfonamides / pharmacology

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin II Type 2 Receptor Blockers
  • Cyclooxygenase Inhibitors
  • Imidazoles
  • Nitrobenzenes
  • Pyridines
  • Receptor, Angiotensin, Type 1
  • Sulfonamides
  • Angiotensin II
  • N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
  • PD 123319
  • Basigin
  • Cyclooxygenase 2
  • Losartan
  • Dinoprostone